Oncolytics Biotech (ONCY) Cash from Operations (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly Cash from Operations came in at 20093380.0 in Q4 2025, down 257.75% year-on-year from 12737247.67 in Q4 2024, and down 315.77% on a QoQ basis from 4832849.4 in Q3 2025.
Oncolytics Biotech (ONCY) Cash from Operations (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 17 years of Cash from Operations data on file, last reported at 20093380.0 in Q4 2025.
- On a quarterly basis, Cash from Operations fell 257.75% year-over-year to 20093380.0 in Q4 2025; TTM through Dec 2025 was 33403281.75, a 69.67% decrease from a year earlier, with the FY2025 full-year figure at 20112000.0, down 1.15% from the prior year.
- Cash from Operations for Q4 2025 stood at 20093380.0, down from 4832849.4 in the prior quarter.
- Over the last five years, Cash from Operations for ONCY reached as high as 2965526.77 in Q3 2021 and fell as low as 20093380.0 in Q4 2025.
- Historically, Cash from Operations has averaged 5504629.65 across 5 years, with a median of 4884324.81 in 2022.
- Across the five-year window, Cash from Operations surged 35.46% in 2021 and tumbled 257.75% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 5025518.31 in 2021, then gained by 12.94% to 4375278.76 in 2022, then slipped by 2.81% to 4498295.57 in 2023, then retreated by 24.86% to 5616552.36 in 2024, then tumbled by 257.75% to 20093380.0 in 2025.
- Per Business Quant data, the three most recent Cash from Operations figures were 20093380.0 in Q4 2025, 4832849.4 in Q3 2025, and 3948489.08 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | -20.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.09 Mn |
| Dec 31, 2025 | -20.09 Mn |
| Sep 30, 2025 | -4.83 Mn |
| Sep 30, 2025 | -4.83 Mn |
| Jun 30, 2025 | -3.95 Mn |
| Jun 30, 2025 | -3.95 Mn |
| Mar 31, 2025 | -4.53 Mn |
| Mar 31, 2025 | -4.53 Mn |
| Dec 31, 2024 | -5.62 Mn |
| Dec 31, 2024 | -5.62 Mn |
| Sep 30, 2024 | -3.54 Mn |
| Sep 30, 2024 | -3.54 Mn |
| Jun 30, 2024 | -4.99 Mn |
| Jun 30, 2024 | -4.99 Mn |
| Mar 31, 2024 | -5.54 Mn |
| Mar 31, 2024 | -5.54 Mn |
| Dec 31, 2023 | -4.50 Mn |
| Dec 31, 2023 | -4.50 Mn |
| Sep 30, 2023 | -4.50 Mn |
| Sep 30, 2023 | -4.50 Mn |